Deric L. Wheeler, Ph.D.
Affiliations: | 2004 | University of Wisconsin, Madison, Madison, WI |
Area:
Oncology, Cell Biology, BiochemistryGoogle:
"Deric Wheeler"Mean distance: (not calculated yet)
Parents
Sign in to add mentor| Ajit K. Verma | grad student | 2004 | UW Madison | |
| (Protein kinase Cepsilon signal transduction pathways to the development of squamous cell carcinoma and a myeloproliferative -like disease.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Guo L, Mohanty A, Singhal S, et al. (2023) Targeting ITGB4/SOX2-driven lung cancer stem cells using proteasome inhibitors. Iscience. 26: 107302 |
| Kostecki KL, Iida M, Wiley AL, et al. (2023) Dual Axl/MerTK inhibitor INCB081776 creates a proinflammatory tumor immune microenvironment and enhances anti-PDL1 efficacy in head and neck cancer. Head & Neck |
| Toulany M, Iida M, Lettau K, et al. (2022) Targeting HER3-dependent activation of nuclear AKT improves radiotherapy of non-small cell lung cancer. Radiotherapy and Oncology : Journal of the European Society For Therapeutic Radiology and Oncology. 174: 92-100 |
| Iida M, McDaniel NK, Kostecki KL, et al. (2022) AXL regulates neuregulin1 expression leading to cetuximab resistance in head and neck cancer. Bmc Cancer. 22: 447 |
| Brand TM, Iida M, Corrigan KL, et al. (2021) Retraction. Science Signaling. 14: eabn0168 |
| Srivastava S, Pang KM, Iida M, et al. (2020) Activation of EPHA2-ROBO1 Heterodimer by SLIT2 Attenuates Non-canonical Signaling and Proliferation in Squamous Cell Carcinomas. Iscience. 23: 101692 |
| Tiwari A, Iida M, Kosnopfel C, et al. (2020) Blocking Y-Box Binding Protein-1 through Simultaneous Targeting of PI3K and MAPK in Triple Negative Breast Cancers. Cancers. 12 |
| McDaniel NK, Iida M, Nickel KP, et al. (2020) AXL mediates cetuximab and radiation resistance through tyrosine 821 and the c-ABL kinase pathway in head and neck cancer. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research |
| Iida M, Harari PM, Wheeler DL, et al. (2020) Targeting AKT/PKB to improve treatment outcomes for solid tumors. Mutation Research. 111690 |
| Tan YC, Srivastava S, Won BM, et al. (2019) EPHA2 mutations with oncogenic characteristics in squamous cell lung cancer and malignant pleural mesothelioma. Oncogenesis. 8: 49 |